Mind Medicine (MindMed) Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-125.32	-95.73	-56.8	-93.04	-33.94	-
Depreciation & Amortization	2.88	3.16	3.18	2.62	0	0
Share-Based Compensation	16.21	15.49	13.71	42.72	7.41	0.07
Other Operating Activities	38.59	12.71	-10.23	1.88	2.93	-3.27
Operating Cash Flow	-67.63	-64.37	-50.14	-45.82	-23.6	-3.2
Acquisitions	0	0	0	-0.3	0	0
Investing Cash Flow	0	0	0	-0.3	0	0
Share Issuance / Repurchase	176.54	7.69	43.21	98.82	97.1	9.9
Debt Issued / Paid	15	15	0	0	0	0
Other Financing Activities	-1.03	-0.84	15.84	-	-0.4	-
Financing Cash Flow	190.51	21.85	59.05	98.82	96.7	9.9
Exchange Rate Effect	0.04	0.08	-0.31	0.74	0.28	0
Net Cash Flow	122.92	-42.44	8.6	53.45	73.39	6.7
Free Cash Flow	-67.63	-64.37	-50.14	-45.82	-23.6	-3.2
Free Cash Flow Per Share	-1.41	-1.64	-1.63	-1.67	-1.33	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).